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Body Mass Index at a Medium Secure Unit: A Four-Year Service 
Evaluation 
 
Yasir Abbasi, Stephanie Bowley, Simon Matta, Darran Bloye 
 
This study investigated changes in body mass index (BMI) in male patients at a medium 
secure unit (MSU) and the subsequent effects of several healthy initiatives over a period of 
four years. Data was collected from 2005 to 2009 and BMI was calculated on admission and 
subsequently at least once a year. 
 
Results 
 
The average BMI increased markedly over the years. A significant number of patients shifted 
from being overweight to clinically obese. Weight gain occurred mostly in the first year of 
admission and in most patients efforts to ensure a healthier lifestyle were unsuccessful.  
 
Clinical Implications 
 
The physical health of patients in secure units needs to be prioritised and healthy lifestyle 
choices maximised, particularly in the first year following admission. Obesity management 
requires a person-centered approach, but a pragmatic shift in attitudes, of both patients and 
staff, towards calorie intake is also required. 
 
Key words: Schizophrenia, Weight gain, Secure units, Obesity, Antipsychotics, Body Mass 
Index. 
 
Introduction 
 
It is well established that excess body fat significantly increases morbidity. Body mass index 
(BMI) is an easy, cheap and non-invasive means of assessing excess body fat (National 
Obesity Observatory 2009). Bjorntorp (1993) has termed the current obesity epidemic as 
‘civilization syndrome’, implying that the positive energy balance (i.e. more calorie intake and 
less exercise) is dependent on the modern urbanised environment of physical inactivity, 
stress, smoking and alcohol consumption.  
 
The Health Survey for England (2004) showed that only 29 per cent of the adult male 
population had a BMI in the desirable range of 20 to 25. 42 per cent on the other hand were 
overweight (BMI= 25 to 30) and 23 per cent were obese (BMI ≥30). In addition, almost 1 per 
cent had a BMI of 40 and above. The survey also revealed that between 1993 to 2004, 
the number of individuals classed as obese had almost doubled.  
 
Obesity is associated with significant morbidity, including hypertension, ischaemic heart 
disease, type 2 diabetes, dyslipidemia and certain malignancies (Newcomer 2005).  
 
A diagnosis of mental illness has also been associated with weight gain. This is particularly 
marked in patients suffering from schizophrenia (Goethelf et al 2000). 
 
Antipsychotics, particularly atypicals, such as clozapine, risperidone and olanzapine, used in 
the treatment of psychotic illnesses such as schizophrenia, have been associated with 
weight gain and the development of metabolic syndrome (Newcomer 2000; Leadbetter et al 
1992; Tadger et al 2008). This is a condition characterised by weight gain (central obesity), 
hypertension, dyslipidemia and insulin resistance.  
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The National Institute of Clinical Excellence guidelines (NICE Obesity 2006) recommend 
multi-component interventions for weight management. This includes increasing physical 
activity, improving eating behaviour and quality of diet and reducing energy intake (calorie 
restriction). 
 
Medium secure units (MSU) provide care for relatively long-stay patients in a highly 
regulated environment. Patients in MSUs are relatively inactive and have access to high 
calorie food.  
 
This service evaluation aims to establish trends in weight gain among inpatients at an MSU 
and the effects of several public health interventions over a four year period. 
 
Method 
 
The hospital is a 60 bed medium secure unit that admits males between 18 and 65 years 
with a primary diagnosis of mental illness (predominantly schizophrenia).  
 
On admission all patients have a thorough physical assessment that includes height and 
weight measurements, general and systemic examinations, baseline blood tests and review 
of any co-morbidities. In the current study we chose to focus on BMI and therefore elected 
not to use data from the other parameters. 
 
In this study, we set out to evaluate the management of physical health of adult inpatients on 
our unit. We investigated one specific aspect of this service provision, i.e. whether all 
inpatients had their weight and BMI measured on admission and at least once yearly 
subsequently. All consenting inpatients were weighed. However, this did not always cover 
the whole inpatient population as some patients either refused to participate or were too 
unwell to be included in the study. One of the authors (SB) kept a record of all patients 
having had a physical health review and measured the weight and calculated their BMIs at 
least once every year. The staff on the ward took consent from patients before they were 
weighed and documented it in the notes. 
 
Following initial weighing on admission, patients were weighed at least yearly until the end of 
the study in April 2009. All data collected were then anonymised and entered into a secure 
database. Statistical analyses, including descriptive tests, were performed. The findings 
were presented to peers at the local clinical governance meetings. The clinical implications 
of the study were extensively discussed and recommendations for improving the service 
were put forward. These proposals were implemented in subsequent years and their impacts 
evaluated. 
 
Results 
 
Population, Duration of Stay and Medication 
The unit occupancy and inpatient population varied at the different sampling points. In 
August 2005 we were able to record data from 52 patients, 40 in February 2006, 44 in 
November 2006, 52 in July 2007, 51 in February 2008 and 46 in April 2009. The variation is 
also partly secondary to refusal to consent and inability to participate due to severity of 
illness at the time. The unit admits male patients only. 94 per cent were white British, 4 per 
cent Afro-Caribbean and 2 per cent Asian in origin 
The overall mean duration of admission was 28.7 months. 31 per cent of patients had been 
inpatients for more than 26 months and a further 17 per cent had been in hospital for more 
than 48 months. This represented the general trend at the unit and was not specific to the 
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study period. The samples at each point were somewhat different as some new patients 
were admitted whilst others were discharged through the four year course of the study. 
There were only nine inpatients who had been there for more than four years and hence 
were represented in each study cycle. Therefore, the patient sample was somewhat different 
at the end when compared to the beginning. 
The vast majority of patients were prescribed regular atypical antipsychotic medication. 37 
per cent were on clozapine tablets, 14 per cent on risperidone depot, 12 per cent were on 
typical antipsychotic depot (zuclopenthixol, flupentixol, fluphenazine, haloperidol), 11% on 
risperidone tablets, 10 per cent on olanzapine tablets, 9 per cent on quetiapine tablets, 7 per 
cent on aripiprazole tablets, 5 per cent on amisulpride tablets and the remaining 3 per cent 
were on either haloperidol or sulpride tablets. 4 per cent of patients were not prescribed any 
antipsychotics. Up to 11 per cent of patients were on two or more antipsychotics 
simultaneously.  
Change in Body Mass Index (BMI) 
BMIs of patients on admission are compared to the general male population in Figure 1. The 
‘BMI on admission’ in this graph represents the average BMI of all the newly admitted 
patients (n =111) over the course of the study.  
 
There is a wide range of patient weight change over the duration of the study, varying from -
8.5kg (weight loss) to + 65kg (weight gain). However the mean BMI at each sampling point 
exceeds the mean BMI of the general population such that a significant percentage of 
patients at each sampling point are clinically obese (BMI ≥30).  
 
Moreover, there is a net increase in the number of overweight and obese patients at each 
sampling point and a significant number of patients shifted from the overweight to the obese 
category (Figure 1). 51 per cent of the all the inpatients (n =111) weighed over the course of 
four years gained an average of 14.1 kilograms (range = 4kgs to 38kgs) in the first year of 
their admission to the unit. 
 
Figure 1: Weight Categorisation by BMI 
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It appears that the most rapid increase in weight occurs in the few months following 
admission after which there is little variation. Subset analysis of a small sample of five 
patients, who were admitted around the same time (August - October 2006) and followed for 
approximately three years, shows that the steepest rise in weight gain (mean increase in 
BMI = 10.2) occurred in the first 12 months following admission. The weight gain of these 
patients has yet to plateau although all of them were already clinically obese in the most 
recent analysis.  
 
Admission data for a group of patients (2009 cohort, n=46, mean duration of stay 23 months) 
was retrospectively reviewed for changes in BMI (Table 1). The data confirms weight gain 
over duration of hospital stay.  
 
Table 1: BMI changes in the April 2009 cohort (n=46) 
 
BMI Mean (s.d)  95% CI 
Admission  27.6 (5.31) 26 – 29.2
April 2009  30.6 (5.05) 29.1 - 32.1
Net Change  +3.04 (3.88) 1.89- 4.19
 
BMI - Body mass index 
s.d. - Standard Deviation 
95% CI - (95% Confidence Interval) 
N - number of patients 
 
Non-Pharmacological Management of Weight Gain 
 
Between 2005 and 2008, as the study progressed, interim results were discussed at clinical 
governance meetings at least yearly. In response to our findings, the unit promoted hospital-
wide public health and individual care plans between 2006 and 2009, aimed at addressing 
the high rates of obesity. 
  
A plated meals service to reduce variation in portion size was introduced. There was also a 
promotion of healthier options on the hospital’s catering menu and in vending machines. 
Inpatients therefore had access to healthier foods with less energy contents (such as fruits 
and vegetables). The vending machine items were also replaced from high calorie food to 
those with fewer calories and less energy (such as whole-meal grain bars, diet soft drinks 
etc.).  
 
The ordering of high calorie take-away foods by patients was limited to once a week (prior to 
this study patients could order take-away foods as often as they wanted to). Limits were also 
imposed on foods introduced into the hospital via carers and patients going on shopping 
trips. 
 
Finally, healthy living groups were set up to promote healthy dieting and exercise. Patients 
were encouraged to attend these groups, however few did. 
 
Despite these initiatives, there was a steady increase in patients’ weight in each study 
sample. The most substantial rise in mean BMI occurred between July 2007 and February 
2008. This may have been related to the introduction of a hospital-wide smoke-free policy in 
April 2007. 
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Figure 2: Mean BMI Following Healthy Living Initiatives 
 
 
 
Discussion 
 
Admission to a medium secure unit can possibly result in weight gain for patients. The 
causes of weight gain in a relatively closed institution are probably multi-factorial in origin, 
reflecting restricted physical activity, the ready availability and consumption of high calorie 
food. Other causes not incorporated in the study may be illness-related (e.g. negative 
symptoms of schizophrenia), medication-related (e.g. sedation and weight gain due to 
antipsychotics), age-related (older people are more likely to gain weight) and/or ethnicity-
related. These associations could have been explored further and are being considered for 
future projects at the unit. 
 
Smoking cessation is known to be associated with weight gain (Matsushita et al 2010; 
Munafo et al 2009) and in the course of our study a smoke-free policy was introduced in 
2007 which in all probability contributed significantly to the subsequent peak in weight gain 
observed. 
 
Weight gain in individuals with mental disorders, can deleteriously affect medication 
adherence and rate of relapse (Weiden et al 2004). These consequences of weight gain can 
be prevented through dietary modification and physical activity, which are basic and 
essential components of a healthy lifestyle programme.  
 
We found that limiting calorie intake was difficult to achieve at the unit. Initiatives aimed at 
curbing weight gain were resisted by many staff and patients. They were criticized as being 
punitive, restrictive and denying choice to a patient population with restricted liberty. 
Attempts to reduce calorie intake across the unit as a whole or through targeted care 
planning thus proved unsuccessful.  
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Implementing lifestyle changes are always tough to accomplish. It is therefore, not only 
important to assess the willingness, readiness and motivation of the patient to change but 
we also need to encourage healthy lifestyle for staff working within such units to help and 
create a healthier ethos. Education for patients and staff alike about the hazards of obesity 
may be the first and most important step in this process. 
 
For individuals who are overweight or obese, reduction in weight is more likely to be 
successfully achieved by setting realistic targets for weight loss (0.5-1 kg/week), providing 
pragmatic options for physical activity and constantly encouraging healthy eating in general 
i.e. decrease calorie intake (NICE Obesity 2006). There is also a role for motivational 
interviewing which helps patients have a healthy dietary intake and improve involvement in 
physical exercise (Marley et al 2011). It works by highlighting and then helping them to 
resolve their ambivalence towards a healthy lifestyle. 
 
Weight management and fitness programmes can help achieve reduction in BMI and waist 
size in a high secure environment (Cormac et al 2008). With regards to antipsychotic 
induced weight gain, drugs such as clozapine and olanzapine can be introduced gradually in 
order to minimise dose-dependent metabolic side effects (Simon et al 2009). Alternatively, 
agents such as Metformin may also have a role to play in the management of antipsychotic 
induced weight gain (Wu et al 2008). More research is needed to help us understand the 
role of established anti-obesity pharmacological interventions such as Orlistat and 
Sibutramine in our patient group (NICE Obesity 2006). 
 
The study population had a mean BMI comparable to the general population at the time of 
admission and gained weight despite regular monitoring and healthy lifestyles interventions. 
This demonstrates that sometimes en-masse policies are not able to cater for individual 
needs. Any future policy making should incorporate person-centred care, taking into account 
individual needs and preferences.  
 
Secure units are ‘obesogenic’ environments and this has important long-term implications for 
the physical health and emotional well-being of patients. Individuals, who become 
overweight in secure units through lack of physical activities and healthy food options or as a 
result of treatment with antipsychotics, could potentially hold the hospital liable for failing to 
protect their physical health.  
 
The legal and ethical issues surrounding the desirability of additional restrictions on calorie 
intake for patients in secure units are complex. An increasingly risk averse culture has led to 
more paternalistic restrictions in certain areas, such as smoke-free or child visiting policies, 
whereas more liberal attitudes to food consumption prevail. Hence, we need to first build 
consensus amongst mental health policy makers on this issue and develop clear national 
guidelines targeting obesity in general and in particular for patients who have gained 
excessive weight secondary to their clinical management.  
 
Should long-stay institutions adopt a more assertive public-health approach to inpatient 
obesity? This would entail careful design of menus, ensuring nutritional balance whilst 
setting limits on calorie intake, combined with the imposition of strict curbs on foods brought 
into the unit. At the same time these institutions would be obliged to provide a range of 
accessible physical activities and health promotion as part of general rehabilitation.  
 
Some patients may not wish to consume healthy foods or engage in a healthier lifestyle and 
if they have capacity with regards to these decisions, it could be argued that we have to 
respect them, however unwise they may be. However, we also have a duty to look after 
individuals under our care holistically, ensuring that both their physical and mental health 
needs are met.  
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A change in culture and attitude of both staff and patients towards excessive weight gain 
may hold the key to winning the ‘war on obesity’ in secure units. 
 
Clinical Implications 
 
Primary prevention of obesity is probably more achievable than a cure and has the ability to 
be more effective, acceptable, cost-efficient and beneficial (Alvarez-Jiménez et al 2008). 
Obesity prevention should include educating staff and patients alike about the risks of weight 
gain, more robust monitoring and classification of obesity and mandatory provision of multi-
component interventions for lifestyle change, including access to psychological therapies like 
motivational enhancement therapy. The critical period for health promotion interventions 
appears to be the first few months of hospital admission and it is suggested that this should 
be the target of future health promotion interventions.  
 
Strengths and Limitations of the Study 
 
The prescribing trends and changes to medication were not part of the study objectives; this 
could have had an impact on our understanding of weight gain at the unit and potentially 
help in highlighting medications which were more responsible than others in causing weight 
gain.  
 
Our study did not use subdivisions of BMI as recommended by NICE guidelines (December 
2006) which states that people classified as obese should be categorized as obesity I (BMI 
30- 34.9), obesity II (BMI 35- 39.9) and obesity III (BMI 40 or more). The risks should then be 
assessed by comparing their BMI classification against waist circumference. It is also known 
that BMI may be less accurate in highly muscular people, Asian adults and older people. 
Other parameters such as waist/hip ratio, measuring skin fold thickness (over the biceps, 
triceps or below the shoulder etc) could have been a better indicator of excess body fat.  
 
The suggestion of rapid weight gain occurring in the first 12 months is based on a very small 
subsample (five patients) and as previously discussed, the observation may have been due 
to multiple confounding factors. We acknowledge that the most significant rise in weight 
coincided with the introduction of a hospital wide no smoking policy. Furthermore, 
comparisons drawn on variations in BMI at different sampling times with different study 
samples may possibly not be generalisable. Hence, future service evaluation efforts at the 
unit would be focused around individual analysis of the admission ward and long stay ward 
(acutely disturbed admission ward patients v very settled patients in rehabilitation). We also 
plan to incorporate other parameters of physical health (e.g. baseline bloods) in future 
studies. 
 
To our knowledge no other study in the UK on weight gain in secure units has incorporated 
data extending over a period of four years.  
 
This study has highlighted that weight gain is a major problem in our patient group. It has 
assisted us in reflecting on this matter and initiated a process of change at the unit towards a 
healthier future. 
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